Alembic Pharmaceuticals successfully completes USFDA inspection at Baroda facility

10 Mar 2017 Evaluate

Alembic Pharmaceuticals’ Bioequivalence Facility located at Baroda was successfully inspected by US Food & Drug Administration (USFDA) from March 6, 2017 to March 10, 2017. There were no 483s issued by USFDA at the end of the inspection.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company manufactures and markets generic pharmaceuticals products all over the world.


Alembic Pharma Share Price

979.40 -4.45 (-0.45%)
28-Mar-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.50
Dr. Reddys Lab 6171.85
Cipla 1494.65
Zydus Lifesciences 1013.75
Lupin 1617.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.